Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.
about
Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fractureAndrogen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer.Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancerA Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal OestradiolImpact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanRelationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer.Bone health management in men undergoing ADT: examining enablers and barriers to care.Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trialOsteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer.American Cancer Society prostate cancer survivorship care guidelines.Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators.Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.
P2860
Q26801227-FD1C952B-D4DE-4DFC-A32D-A78D62ACD175Q33736308-73328E8A-93E8-4A47-8E58-33DDB7D09975Q33877542-FEF0010C-D905-4A8E-B7F7-CE60F37493BDQ36861650-F709F7B8-BF30-4684-AC1C-D476C2A1E1B7Q38186795-D02A160F-D38F-46C3-9427-F57C0DF16E08Q40834657-595CC135-52B9-4134-AB4C-B8290FCFDDDFQ41666599-9C9A7A52-5BA0-4798-8B5E-C7F17DE8CFC2Q41728305-A3BA05FA-EE91-4A8A-9D5A-887C3D6344EDQ42281198-C6191E99-7FE3-45BA-8C27-E20C32BC70C7Q43720651-7B322955-75A7-453D-B322-DED08CB8221DQ47138098-FEBCDD2F-8B68-4E61-BD21-D65C66926DDBQ47619304-B17B2944-63F5-4C7E-97D6-8D8C4B887C5AQ48073617-6BC5F610-1754-42FA-94B8-1D0B7D93D884Q50862712-CF6BD192-EB9A-4518-8C22-232F17BAB3E9Q54774472-1A08B23E-2ABB-441C-B77E-13332B6927EEQ55322511-6BDD5FC9-9177-4E97-9B11-7BAF12577D2A
P2860
Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Fracture after androgen depriv ...... isk of skeletal complications.
@ast
Fracture after androgen depriv ...... isk of skeletal complications.
@en
type
label
Fracture after androgen depriv ...... isk of skeletal complications.
@ast
Fracture after androgen depriv ...... isk of skeletal complications.
@en
prefLabel
Fracture after androgen depriv ...... isk of skeletal complications.
@ast
Fracture after androgen depriv ...... isk of skeletal complications.
@en
P2093
P2860
P1433
P1476
Fracture after androgen depriv ...... isk of skeletal complications.
@en
P2093
Dirk F Moore
Grace L Lu-Yao
Thomas L Jang
Weichung Shih
Yu-Hsuan Shao
P2860
P304
P356
10.1111/J.1464-410X.2012.11758.X
P577
2013-01-17T00:00:00Z